Europe Respiratory Therapeutic Devices Market Share

Europe Respiratory Therapeutic Devices Market Overview

Europe Respiratory Therapeutic Devices Market Size was valued at USD 3.8 billion in 2022. The Europe Respiratory Therapeutic Devices market is projected to grow from USD 4.2 Billion in 2023 to USD 7.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9% during the forecast period (2023 - 2032). Respiratory disorders are becoming more common in emerging nations, the world's aging population is growing, and technological advancement in wealthy nations is the key market driver enhancing Europe Respiratory Therapeutic Devices market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Respiratory Therapeutic Devices Market Trends

• Rise in respiratory diseases and the need for therapeutic gadgets for home care will boost the market growth

Infectious respiratory illnesses directly influence the demand for respiratory care. The most recent and serious of these illnesses is COVID-19; due to the epidemic, demand for ventilators and other personal protective equipment has increased significantly. The COVID-19 epidemic has increased the need for ventilators, which has led to governmental and commercial backing for accelerating manufacture. This demonstrates the importance placed on respiratory treatment in the context of an outbreak; as a result, a good growth rate in the Europe Respiratory Therapeutic Devices market is anticipated. The Respiratory Therapeutic Devices Market's growth drivers are in charge of boosting the market's growth rate. The primary market drivers are the home therapeutics devices lower costs. Some significant motivators are the significant increase in patients with chronic respiratory disorders and rising healthcare expenses. The increasing demand for items including nebulizers, ventilators, and CPAP machines for treating, diagnosing, and monitoring patients with respiratory disorders in home care settings primarily drives the Europe Respiratory Therapeutic Devices market CAGR.

The primary reasons influencing the growth of the home healthcare market are the fast increase in the world's senior population, the growing prevalence of chronic illnesses (including COPD and asthma), and the cost benefits of home care equipment and services (compared to hospital visits). The high growth potential of emerging markets, the decentralization of healthcare, and the development of miniaturized equipment are some of the key drivers anticipated to provide companies in the respiratory home healthcare market with considerable growth prospects. Many individuals with chronic respiratory illnesses choose to get care in home care settings due to the growing expense of healthcare. As patients utilize these items in home care settings to treat, diagnose, and monitor a range of respiratory ailments, this trend is anticipated to raise demand for goods such as nebulizers, ventilators, and CPAP equipment. Thus, it is anticipated that this aspect will accelerate Europe Respiratory Therapeutic Devices market revenue.

Europe Respiratory Therapeutic Devices Market Segment Insights

Europe Respiratory Therapeutic Devices Product Insights

The Europe Respiratory Therapeutic Devices market segmentation, based on Product, includes Nebulizers, Humidifiers. The Humidifiers evices segment, held the majority share in 2022 contribution to around ~65-67% concerning the Europe Respiratory Therapeutic Devices market revenue. This is a result of the growing demand for medicinal purposes. A rise in the demand for humidifiers in homes, hospitals, schools, and healthcare facilities is anticipated to boost the Europe Respiratory Therapeutic Devices market for humidifier filters since filters are necessary to prevent the growth of bacteria and fungus in the air that is circulated. Also fueling market expansion is the requirement for filters in humidifiers, which is brought on by the increase in the prevalence of airborne diseases like T.B.

Figure 1: Europe Respiratory Therapeutic Devices Market, by Product, 2022 & 2030 (USD billion)Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Respiratory Therapeutic Devices Technology Insights

The Europe Respiratory Therapeutic Devices market segmentation, based on Technology, includes Electrostatic Filtration and HEPA. The HEPA segment dominated the Europe Respiratory Therapeutic Devices market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. HEPA filters are utilized in various therapeutic respiratory equipment to capture and remove particles. The CDC mandates that therapeutic equipment have HEPA filtration technology for air filtration. The frequency of respiratory illnesses and the way they spread are two factors that contribute to the demand for HEPA filters. Hence, rising applications of HEFA filters for Europe Respiratory Therapeutic Devices positively impact the market growth.

Europe Respiratory Therapeutic Devices Application Insights

The Europe Respiratory Therapeutic Devices market data has been bifurcated by Application into Asthma, COPD, and Cystic Fibrosis. The minimally invasive spine surgery segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period 2022-2030. Due to environmental factors and the rising smoking frequency, COPD has a significant Europe Respiratory Therapeutic Devices market share. After asthma, this market category is anticipated to develop faster. Those with COPD will be impacted by the current COVID-19 epidemic. While they do not have an increased chance of getting the condition, it can negatively affect these people. Thus, it is anticipated that the high incidence of COPD and the rising number of COPD-related fatalities will fuel demand for respiratory care devices over the projection period.

Europe Respiratory Therapeutic Devices End User Insights

Based on End Users, the Europe Respiratory Therapeutic Devices industry has been segmented into Hospitals, Home Care. Multispecialty hospitals held the largest segment share in 2022, owing to the rapid adoption of advanced Europe Respiratory Therapeutic Devices and surgery products and the availability of skilled medical staff. Moreover, increasing government initiatives to improve the healthcare infrastructure and the growing number. In Europe, Respiratory Therapeutic Devices surgeries such as minimally invasive spine surgery and other segments are expected to bolster at a CAGR of 3.17% during the assessed timeline.

Europe Respiratory Therapeutic Devices Regional Insights

By Region, the study provides market insights into Germany, France, U.K. and Rest of the Europe. Germany Europe Respiratory Therapeutic Devices market accounted for USD 1.7 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. Asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, and pneumonia are just a few of the respiratory illnesses and disorders that are predicted to have a rising impact on the market for respiratory devices in Europe. Also, the Europe Respiratory Therapeutic Devices market expansion is anticipated to be boosted by technical developments resulting in the creation of sophisticated and effective technologies for diagnosing sickness. The Europe Respiratory Therapeutic Devices market is also expanding due to rising investments in the construction of medical and healthcare facilities and an increase in screening tests and diagnostic procedures.

Further, the major countries studied in the market report are The Germany, France, the U.K., Italy, Spain and Brazil.

Figure 2: EUROPE RESPIRATORY THERAPEUTIC DEVICES MARKET SHARE BY REGION 2022 (%)Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Due to increased preterm birth rates and a growing senior population, the German respiratory equipment industry thrives in Europe. Factors behind the surge include the fact that rapid urbanization has degraded air quality and increased pollution. Additionally, increasing the risk of respiratory illnesses and Europe Respiratory Therapeutic Devices market demand are smoking practices.

Due to the growing elderly population in the area, the respiratory device markets in the U.K. and France are also anticipated to expand significantly. The likelihood of respiratory illnesses has also grown due to people's urbanization and smoking habits, which has raised market demand.

Europe Respiratory Therapeutic Devices Key Market Players & Competitive Insights

Leading market players are investing a lot of money in R&D to expand their product portfolios, which will spur further market growth for Europe's Respiratory Therapeutic Devices. With significant industry changes, including new product releases, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations, market developments are also undertaking various strategic activities to expand their global presence. To grow and remain in a market that is becoming more and more competitive, Europe's Respiratory Therapeutic Devices industry competitors must provide affordable products.

Manufacturing locally to cut operational costs is one of the main business tactics used by the Europe Respiratory Therapeutic Devices industry to serve customers and increase the market sector. The Europe Respiratory Therapeutic Devices industry has recently given medicine some of the most important advantages. In the Europe Respiratory Therapeutic Devices markets, major players such as ResMed, Inc., Chart Industries (Airsep Corporation), CareFusion Corporation, Covidien Plc, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V. (Philips Healthcare), Masimo Corporation, Maquet Getinge Group, Invacare Corporation, GE Healthcare, and others are working on expanding the market demand by investing in research and development activities.

The medical equipment business ResMed Inc. is situated in San Diego, California. It primarily offers cloud-connected medical equipment to treat sleep apnea, chronic obstructive pulmonary disease, and other respiratory disorders. ResMed introduced AirSense11, a new PAP treatment gadget, in August 2021. It contains a remote software update that makes therapy easier to start and offers comfort at night.

With its headquarters in Mumbai, Cipla Ltd is a worldwide pharmaceutical corporation. Cipla focuses on creating medications to treat various illnesses, including arthritis, diabetes, depression, cardiovascular disease, respiratory diseases, and many more. Cipla introduced Spirofy, a wireless, portable spirometer, in November 2021. It features bacterial and virus filters that make the user comfortable in distant areas without access to electricity and outdoor camping.

Key Companies in the Europe Respiratory Therapeutic Devices market include

• ResMed, Inc.


• Chart Industries (Airsep Corporation)


• CareFusion Corporation


• Covidien Plc


• Fisher & Paykel Healthcare Limited


• Koninklijke Philips N.V. (Philips Healthcare)


• Masimo Corporation


• Maquet Getinge Group


• Invacare Corporation


• E. Healthcare

Europe Respiratory Therapeutic Devices Market Segmentation

Europe Respiratory Therapeutic Devices Product Outlook

• Nebulizers


• Humidifiers

Europe Respiratory Therapeutic Devices Technology Outlook

• Electrostatic Filtration


• HEPA

Europe Respiratory Therapeutic Devices Application Outlook

• Asthma


• COPD


• Cystic Fibrosis

Europe Respiratory Therapeutic Devices End User Outlook

• Hospitals


• Home Care

Europe Respiratory Therapeutic Devices Regional Outlook

• Europe


• Germany


• France


• UK


• Italy


• Spain


• Rest of Europe